Cargando…
Cardiac Manifestations of Rheumatological Conditions: A Narrative Review
Cardiovascular diseases are common in systemic rheumatologic diseases. They can be presented at the time of diagnosis or after diagnosis. The cardiac involvements can be the first presentation of rheumatologic conditions. It means that a patient with rheumatologic disease may go to a cardiologist wh...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scholarly Research Network
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3483730/ https://www.ncbi.nlm.nih.gov/pubmed/23119182 http://dx.doi.org/10.5402/2012/463620 |
_version_ | 1782248052302544896 |
---|---|
author | Owlia, Mohammad Bagher Mostafavi Pour Manshadi, Seyed Mohammad Yousof Naderi, Nafiseh |
author_facet | Owlia, Mohammad Bagher Mostafavi Pour Manshadi, Seyed Mohammad Yousof Naderi, Nafiseh |
author_sort | Owlia, Mohammad Bagher |
collection | PubMed |
description | Cardiovascular diseases are common in systemic rheumatologic diseases. They can be presented at the time of diagnosis or after diagnosis. The cardiac involvements can be the first presentation of rheumatologic conditions. It means that a patient with rheumatologic disease may go to a cardiologist when attacked by this disease at first. These manifestations are very different and involve different structures of the heart, and they can cause mortality and morbidity of patients with rheumatologic diseases. Cardiac involvements in these patients vary from subclinical to severe manifestations. They may need aggressive immunosuppressive therapy. The diagnosis of these conditions is very important for choosing the best treatment. Premature atherosclerosis and ischemic heart disease are increased in rheumatoid arthritis and systemic lupus erythematosus, and may be causes of mortality among them. The aggressive control of systemic inflammation in these diseases can reduce the risk of cardiovascular disease especially ischemic heart disease. Although aggressive treatment of primary rheumatologic diseases can decrease mortality rate and improve them, at this time, there are no specific guidelines and recommendations, to include aggressive control and prevention of traditional risk factors, for them. |
format | Online Article Text |
id | pubmed-3483730 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | International Scholarly Research Network |
record_format | MEDLINE/PubMed |
spelling | pubmed-34837302012-11-01 Cardiac Manifestations of Rheumatological Conditions: A Narrative Review Owlia, Mohammad Bagher Mostafavi Pour Manshadi, Seyed Mohammad Yousof Naderi, Nafiseh ISRN Rheumatol Review Article Cardiovascular diseases are common in systemic rheumatologic diseases. They can be presented at the time of diagnosis or after diagnosis. The cardiac involvements can be the first presentation of rheumatologic conditions. It means that a patient with rheumatologic disease may go to a cardiologist when attacked by this disease at first. These manifestations are very different and involve different structures of the heart, and they can cause mortality and morbidity of patients with rheumatologic diseases. Cardiac involvements in these patients vary from subclinical to severe manifestations. They may need aggressive immunosuppressive therapy. The diagnosis of these conditions is very important for choosing the best treatment. Premature atherosclerosis and ischemic heart disease are increased in rheumatoid arthritis and systemic lupus erythematosus, and may be causes of mortality among them. The aggressive control of systemic inflammation in these diseases can reduce the risk of cardiovascular disease especially ischemic heart disease. Although aggressive treatment of primary rheumatologic diseases can decrease mortality rate and improve them, at this time, there are no specific guidelines and recommendations, to include aggressive control and prevention of traditional risk factors, for them. International Scholarly Research Network 2012-10-17 /pmc/articles/PMC3483730/ /pubmed/23119182 http://dx.doi.org/10.5402/2012/463620 Text en Copyright © 2012 Mohammad Bagher Owlia et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Article Owlia, Mohammad Bagher Mostafavi Pour Manshadi, Seyed Mohammad Yousof Naderi, Nafiseh Cardiac Manifestations of Rheumatological Conditions: A Narrative Review |
title | Cardiac Manifestations of Rheumatological Conditions: A Narrative Review |
title_full | Cardiac Manifestations of Rheumatological Conditions: A Narrative Review |
title_fullStr | Cardiac Manifestations of Rheumatological Conditions: A Narrative Review |
title_full_unstemmed | Cardiac Manifestations of Rheumatological Conditions: A Narrative Review |
title_short | Cardiac Manifestations of Rheumatological Conditions: A Narrative Review |
title_sort | cardiac manifestations of rheumatological conditions: a narrative review |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3483730/ https://www.ncbi.nlm.nih.gov/pubmed/23119182 http://dx.doi.org/10.5402/2012/463620 |
work_keys_str_mv | AT owliamohammadbagher cardiacmanifestationsofrheumatologicalconditionsanarrativereview AT mostafavipourmanshadiseyedmohammadyousof cardiacmanifestationsofrheumatologicalconditionsanarrativereview AT naderinafiseh cardiacmanifestationsofrheumatologicalconditionsanarrativereview |